Rallybio Corp
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Emerging growth company
State of Incorporation
DE
Business Address
234 CHURCH STREET, NEW HAVEN, CT, 06510
Mailing Address
234 CHURCH STREET, NEW HAVEN, CT, 06510
Phone
203- 859-3820
Fiscal Year End
1231
EIN
851083789
Financial Overview
FY2025 FY
$858K
Revenue
$106.18M
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | March 31, 2026 | View on SEC |
| 10-K Annual financial report | March 16, 2026 | View on SEC |
| 3 Initial insider ownership report | March 10, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | March 6, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | March 6, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | March 3, 2026 | View on SEC |
| 8-K Current report of material events | March 2, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | February 27, 2026 | View on SEC |
| 4 Insider stock transaction report | February 23, 2026 | View on SEC |
| 4 Insider stock transaction report | February 20, 2026 | View on SEC |
Annual Reports
10-K
March 16, 2026
- Proposed all-stock merger with Candid Therapeutics expected to close in Q2 2026, aiming for a diversified pipeline and extended cash runway.
- Positive Phase 2 clinical trial data for lead candidate RLYB116, with Phase 3 pivotal trial initiation planned for mid-2026 and topline data expected in 2028.
Material Events
8-K
Strategy Change
January 29, 2026
High Impact
- Aims to boost stock price per share to meet crucial NASDAQ listing requirements.
- Seeks to make the stock more attractive to a broader range of investors, especially institutional funds.
Insider Trading
SELL
1 insiders
1 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.